Matches in Wikidata for { <http://www.wikidata.org/entity/Q64375572> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q64375572 description "clinical trial" @default.
- Q64375572 description "ensayu clínicu" @default.
- Q64375572 description "klinisch onderzoek" @default.
- Q64375572 description "клінічне випробування" @default.
- Q64375572 description "կլինիկական փորձարկում" @default.
- Q64375572 name "Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy" @default.
- Q64375572 type Item @default.
- Q64375572 label "Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy" @default.
- Q64375572 prefLabel "Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy" @default.
- Q64375572 P1050 Q64375572-0DFB296B-865E-44ED-BF78-E240556EDA5D @default.
- Q64375572 P1132 Q64375572-76D31780-DB46-49AA-9D3A-17A3462994A8 @default.
- Q64375572 P1476 Q64375572-C21BA02A-073B-415D-96EB-E8856936B97C @default.
- Q64375572 P17 Q64375572-13BF108F-7C25-4908-8944-C06D0137B479 @default.
- Q64375572 P17 Q64375572-23107DD2-57C0-4109-BCD5-8AAB6EB5E76B @default.
- Q64375572 P17 Q64375572-4762F3A0-10F2-4E99-BFFB-69FD5164456D @default.
- Q64375572 P17 Q64375572-57C9E671-979E-48DE-B24F-F8030A86F208 @default.
- Q64375572 P17 Q64375572-69C34BB6-5933-4FC4-A0E4-1F1CABEFAC86 @default.
- Q64375572 P17 Q64375572-6EECA498-95F0-4C4B-AF4E-551A397066A8 @default.
- Q64375572 P17 Q64375572-874CD7F2-9B1C-4C4C-8905-7189785F20A0 @default.
- Q64375572 P17 Q64375572-9E3BBAFD-B1EF-44B5-A3FC-1A2ACA38327B @default.
- Q64375572 P17 Q64375572-B3E60EE2-927B-4F95-9178-BDB00CF10690 @default.
- Q64375572 P17 Q64375572-B4286BED-61FB-4E91-B981-39A6428E899D @default.
- Q64375572 P17 Q64375572-C15EB431-39CA-4A31-B9A8-522B661A84DA @default.
- Q64375572 P17 Q64375572-C2734E3D-7907-4284-9170-8C5147C0A3E9 @default.
- Q64375572 P17 Q64375572-C79E3D8C-7DAE-42DB-AA19-4E04C4A56186 @default.
- Q64375572 P17 Q64375572-C902E2DD-04D8-41ED-AE7F-24D2ADECA315 @default.
- Q64375572 P1813 Q64375572-F2538B1E-041F-48B5-A58E-A23701F9041F @default.
- Q64375572 P2899 Q64375572-169270FB-CF52-4253-9F46-72BAB0938B93 @default.
- Q64375572 P3098 Q64375572-726CA538-B134-4AC7-A465-B2CB9390C4FA @default.
- Q64375572 P31 Q64375572-F9FCA7B7-B1E4-4AA1-AB40-A7D83A1E713C @default.
- Q64375572 P580 Q64375572-1D0A96CC-A2B2-4A41-AFCD-D4696E0AEC2C @default.
- Q64375572 P582 Q64375572-6506A94D-3F8E-4A6F-BFD6-2065E57B95D9 @default.
- Q64375572 P6099 Q64375572-480D805A-CBFF-4A4A-9CDC-82EED04CCFE5 @default.
- Q64375572 P8363 Q64375572-FB6574A9-E7E3-4786-A2B9-9B6045CFBB88 @default.
- Q64375572 P1050 Q12206 @default.
- Q64375572 P1132 "+782" @default.
- Q64375572 P1476 "A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of LX4211 as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy" @default.
- Q64375572 P17 Q142 @default.
- Q64375572 P17 Q145 @default.
- Q64375572 P17 Q183 @default.
- Q64375572 P17 Q214 @default.
- Q64375572 P17 Q219 @default.
- Q64375572 P17 Q28 @default.
- Q64375572 P17 Q29 @default.
- Q64375572 P17 Q31 @default.
- Q64375572 P17 Q34 @default.
- Q64375572 P17 Q37 @default.
- Q64375572 P17 Q38 @default.
- Q64375572 P17 Q39 @default.
- Q64375572 P17 Q40 @default.
- Q64375572 P17 Q801 @default.
- Q64375572 P1813 "inTandem2" @default.
- Q64375572 P2899 "+18" @default.
- Q64375572 P3098 "NCT02421510" @default.
- Q64375572 P31 Q30612 @default.
- Q64375572 P580 "2015-05-01T00:00:00Z" @default.
- Q64375572 P582 "2016-11-01T00:00:00Z" @default.
- Q64375572 P6099 Q42824827 @default.
- Q64375572 P8363 Q78089383 @default.